ZA200610124B - Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases - Google Patents

Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases

Info

Publication number
ZA200610124B
ZA200610124B ZA200610124A ZA200610124A ZA200610124B ZA 200610124 B ZA200610124 B ZA 200610124B ZA 200610124 A ZA200610124 A ZA 200610124A ZA 200610124 A ZA200610124 A ZA 200610124A ZA 200610124 B ZA200610124 B ZA 200610124B
Authority
ZA
South Africa
Prior art keywords
compositions
management
treatment
methods
myeloproliferative diseases
Prior art date
Application number
ZA200610124A
Inventor
Jerome B Zeldis
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Priority to ZA200610124A priority Critical patent/ZA200610124B/en
Publication of ZA200610124B publication Critical patent/ZA200610124B/en

Links

ZA200610124A 2004-05-05 2004-05-05 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases ZA200610124B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA200610124A ZA200610124B (en) 2004-05-05 2004-05-05 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA200610124A ZA200610124B (en) 2004-05-05 2004-05-05 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases

Publications (1)

Publication Number Publication Date
ZA200610124B true ZA200610124B (en) 2008-10-29

Family

ID=40908666

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610124A ZA200610124B (en) 2004-05-05 2004-05-05 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases

Country Status (1)

Country Link
ZA (1) ZA200610124B (en)

Similar Documents

Publication Publication Date Title
IL165258A0 (en) Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
IL175074A0 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatement, modification and management of pain
EP1567157A4 (en) Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases
IL178142A0 (en) Methods of using and compositions comprising immunomodulatory compounos for the treatment and management of skin diseases or disorders
AU2003220317A8 (en) Methods and drug delivery systems for the treatment of orofacial diseases
EP1827391A4 (en) Dosage forms and methods of use thereof
EP1804813A4 (en) Formulations and methods for treatment of inflammatory diseases
IL175427A0 (en) Methods and compositions using thalidomide for the treatment and management of cancers and other diseases
IL177849A0 (en) Methods and compositions for treatment of autoimmune diseases
EP1567154A4 (en) Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
IL179038A0 (en) Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
ZA200503241B (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
IL177861A0 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
EP1534295A4 (en) Formulations and methods of administration of cephalotaxines, including homoharringtonine
IL168444A (en) Selective cytokine inhibitory drugs for use in treating, preventing or managing a myeloproliferative diseases, a pharmaceutical composition and a kit comprising same
HK1104800A1 (en) Method of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
EP1744748A4 (en) Method of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myelodysplastic syndromes
EP1605935A4 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
IL179040A0 (en) Methods of using and compositions comrpising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
IL175311A0 (en) Cytokine inhibitory drugs for treatment of macular degeneration
EP1601348A4 (en) Compositions and methods with enhanced therapeutic activity
EP1804880A4 (en) Medical devices and methods of preparation and use
EP1567148A4 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration
ZA200610124B (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
AU2003286931A8 (en) Methods and compositions using thalidomide for the treatment and management of cancers and other diseases